Global Phenylketonuria Treatment Market Share

Statistics for the 2023 & 2024 Global Phenylketonuria Treatment market share, created by Mordor Intelligence™ Industry Reports. Global Phenylketonuria Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Metabolic Disorder Drugs Research Phenylketonuria Treatments Market Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Phenylketonuria Treatment Industry

The phenylketonuria treatment market is consolidated and consists of a few major players. Some of the companies currently dominating the market are BioMarin Pharmaceuticals Inc., Censa Pharmaceutical, Synlogic Inc., Erytech Pharma SA, Codexis Inc., SOM Innovation Biotech SL, Homology Medicines Inc., and Ultragenyx (Dimension Therapeutics).

Phenylketonuria Treatment Market Leaders

  1. BioMarin Pharmaceuticals

  2. SOM Innovation Biotech SL

  3. Homology Medicines Inc.

  4. Censa Pharmaceuticals (PTC Therapeutics)

  5. Codexis Inc.

*Disclaimer: Major Players sorted in no particular order

Picture1.png

Phenylketonuria Treatment Market Report Snapshots

Phenylketonuria Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)